Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nesosteine: a new mucoregulatory agent.

R Scuri, P Mondani, C Frova

    Drugs Under Experimental and Clinical Research
    |January 1, 1986
    PubMed
    Summary

    Nesosteine, a novel molecule, effectively reduced mucus viscosity and increased production in rabbits. This new drug demonstrated superior mucolytic and mucoregulatory activity compared to existing treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

    Physical review letters·2026
    Same author

    Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

    Physical review letters·2026
    Same author

    Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

    Physical review letters·2026
    Same author

    First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

    Physical review letters·2026
    Same author

    Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

    Physical review letters·2026
    Same author

    First Observation of the B[over ¯]_{s}^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay and Evidence for the B[over ¯]^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay.

    Physical review letters·2026

    Area of Science:

    • Pharmacology
    • Biochemistry

    Background:

    • Tracheobronchial mucus plays a vital role in respiratory health.
    • Dysregulation of mucus rheology and production is implicated in various respiratory diseases.
    • Existing mucolytic and mucoregulatory drugs have limitations in efficacy.

    Purpose of the Study:

    • To investigate the effects of a new molecule, nesosteine, on tracheobronchial mucus rheology and production.
    • To compare the efficacy of nesosteine with established mucolytic/mucoregulatory agents.
    • To elucidate the biochemical mechanisms underlying nesosteine's action on mucus components.

    Main Methods:

    • In vivo studies using a rabbit model of induced bronchitis (H2SO4 aerosol).
    • In vitro studies using pig gastric mucin to assess fluidifying activity.
    • Biochemical analysis of tracheobronchial mucus components, including total proteins and specific mucoproteins.

    Main Results:

    • Nesosteine significantly reduced tracheobronchial mucus viscosity in bronchitic rabbits.
    • Nesosteine markedly increased mucoproduction in healthy rabbits.
    • Nesosteine demonstrated superior activity compared to sobrerol, N-acetylcysteine, bromexine, ambroxol, S-carboxymethylcysteine, and mercaptopropionylglycine.
    • In vitro fluidifying activity was observed, though less pronounced than in vivo.
    • Nesosteine reduced total protein content and affected specific mucoproteins (albumin, alpha 1, alpha 2, beta, gamma).

    Conclusions:

    • Nesosteine is a potent mucolytic and mucoregulatory agent with significant potential for treating respiratory conditions.
    • Its efficacy in modifying mucus rheology and production surpasses that of current leading drugs.
    • Nesosteine's mechanism involves reducing mucus protein content, suggesting a novel therapeutic approach.

    Related Experiment Videos